{"id":23569,"date":"2014-05-27T08:49:05","date_gmt":"2014-05-27T12:49:05","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=23569"},"modified":"2014-05-27T08:49:05","modified_gmt":"2014-05-27T12:49:05","slug":"inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569","title":{"rendered":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/27\/2014 (wallstreetpr) \u2013 <b>Inovio Pharmaceuticals Inc (NYSEMKT:INO)<\/b> is developing vaccines for the treatment of cancers and other serious diseases through its patented synthetic vaccine technology. The Company primarily generates revenue from its collaborative R&amp;D projects with major pharma players and grants from the government programs.<\/p>\n<p style=\"text-align: justify;\"><b>Highlights Of First Quarter<\/b><\/p>\n<p style=\"text-align: justify;\">During the first quarter ended March 31, 2014 (1Q2014), Inovio\u2019s total revenue was $2.4 million compared to $1.5 million for the same period 2013. The increase was due to the $1.4 million revenue recognized from the collaboration with Roche and an increase of $308K as grants under NIH research project that partially offset the lower revenue recognized from NIAID contracts.<\/p>\n<p style=\"text-align: justify;\">The Company is leveraging its own technology and developing new treatment measures for chronic diseases and continues to develop new immune therapies against cancer, HIV and Hepatitis. As a result, total operating expenses continued to increase year over year to $12.4 million versus $8.1 million a year ego.<\/p>\n<p style=\"text-align: justify;\">Inovio Pharmaceuticals Inc (NYSEMKT:INO)\u00a0is yet to report positive earnings as most of the funds are utilized in R&amp;D activities and reported operating loss of $10.0 million during the period compared to the loss of $6.6 million in 1Q2013. Subsequent to the operating loss, Inovio posted a net loss of $0.05 per share versus net loss of $0.06 per share during 1Q2013.<\/p>\n<p style=\"text-align: justify;\"><b>Funding Resources <\/b><\/p>\n<p style=\"text-align: justify;\">The Company finances the entire operation either through self funding or the milestone received from the collaborative agreements with its partners. As of March 31, 2014, Inovio increased its net cash balance to $116.8 million and working capital to $106 million due to the $70 million of cash received from the exercise of stocks, warrants and stock options and $6.9 million from the maturities of investment securities.<\/p>\n<p style=\"text-align: justify;\">Inovio Pharmaceuticals Inc (NYSEMKT:INO)\u2019s management believes that the available funds will be sufficient to meet\u00a0its requirement for\u00a0working capital\u00a0till 2017. Moreover, strong partnership in the area of immune therapies may help the Company to bring novel medicines especially vaccines to treat cancers and other chronic diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/27\/2014 (wallstreetpr) \u2013 Inovio Pharmaceuticals Inc (NYSEMKT:INO) is developing vaccines for the treatment of cancers and other serious diseases through its patented synthetic [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":23570,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[6896,2981,2982],"stock_ticker":[],"class_list":["post-23569","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-inovio-pharmaceuticals-inc","tag-inovio-pharmaceuticals-inc-nysemktino","tag-nysemktino","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/27\/2014 (wallstreetpr) \u2013 Inovio Pharmaceuticals Inc (NYSEMKT:INO) is developing vaccines for the treatment of cancers and other serious diseases through its patented synthetic [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-27T12:49:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock\",\"datePublished\":\"2014-05-27T12:49:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg\",\"keywords\":[\"Inovio Pharmaceuticals Inc\",\"Inovio Pharmaceuticals Inc (NYSEMKT:INO)\",\"NYSEMKT:INO\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\",\"name\":\"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg\",\"datePublished\":\"2014-05-27T12:49:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg\",\"width\":275,\"height\":183},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569","og_locale":"en_US","og_type":"article","og_title":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR","og_description":"Boston, MA 05\/27\/2014 (wallstreetpr) \u2013 Inovio Pharmaceuticals Inc (NYSEMKT:INO) is developing vaccines for the treatment of cancers and other serious diseases through its patented synthetic [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-27T12:49:05+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock","datePublished":"2014-05-27T12:49:05+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg","keywords":["Inovio Pharmaceuticals Inc","Inovio Pharmaceuticals Inc (NYSEMKT:INO)","NYSEMKT:INO"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569","url":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569","name":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg","datePublished":"2014-05-27T12:49:05+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/inno.jpg","width":275,"height":183},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/inovio-pharmaceuticals-inc-nysemktino-an-emerging-stock-23569#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Inovio Pharmaceuticals Inc (NYSEMKT:INO): An Emerging Stock"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/23569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=23569"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/23569\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/23570"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=23569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=23569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=23569"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=23569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}